Newsletter Newsletters Events Events Podcasts Videos Africanews
Loader
Advertisement

Von der Leyen cancels appointments for two weeks after falling ill with 'severe pneumonia'

European Commission President Ursula von der Leyen addresses a media conference at the end of an EU summit in Brussels, Thursday, Dec. 19, 2024.
European Commission President Ursula von der Leyen addresses a media conference at the end of an EU summit in Brussels, Thursday, Dec. 19, 2024. Copyright  Jean-Francois Badias/Copyright 2024 The AP. All rights reserved
Copyright Jean-Francois Badias/Copyright 2024 The AP. All rights reserved
By Orestes Georgiou Daniel with AP
Published on Updated
Share this article Comments
Share this article Close Button
Copy/paste the article video embed link below: Copy to clipboard Copied

EU Commission chief von der Leyen has fallen ill with 'severe pneumonia' and has cancelled all her appointments for the next two weeks, her office has announced.

ADVERTISEMENT

European Commission President Ursula von der Leyen has been diagnosed with "severe pneumonia" and has cancelled her engagements for the first two weeks of January, her office announced on Friday.

"She is dealing with severe pneumonia," a spokesperson said in a statement, though he provided no further details on her condition or the cause of her illness.

Her cancelled engagements include a visit to Lisbon where she was due to make a speech, as well as a trip to Gdansk to mark "the occasion of the launch of the Polish Council Presidency, which will take place at a later stage," the spokesperson said.

The EU Commission president did not attend an event in Warsaw on Friday evening where Poland marked the beginning of its six-month EU Council presidency with an opening gala.

At 66, von der Leyen had only just embarked on her second five-year term at the helm of the EU's powerful executive body.

Go to accessibility shortcuts
Share this article Comments

Read more

Ursula von der Leyen's new Commission receives final approval from MEPs

EU's partial suspension of trade with Israel: Appropriate or insignificant?

Sweden and Finland move to safeguard bioenergy production